SCHEMBL7001252

SCHEMBL7001252

CC(=O)ON1CC(=O)c2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.60
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
PABPC1 P11940 1/20 0.42
BLM P54132 1/20 0.42
KMT2A Q03164 1/20 0.42
KCNN4 O15554 3/20 0.41
KCNA3 P22001 3/20 0.41
CES1 P23141 1/20 0.40
KDR P35968 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
RAB9A P51151 2/20 0.36
TRPA1 O75762 1/20 0.36
NPC1 O15118 1/20 0.36
MTOR P42345 1/20 0.36
HSD17B3 P37058 1/20 0.36
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6126239 0.79 NOTUM (0.53) NOTUMALDH1A1KDM4EMEN1CYP3A4
SCHEMBL30003296 0.75 NOTUM (1.00) NOTUMALDH1A1KDM4EKCNN4KCNA3
SCHEMBL1048074 0.75 NOTUM (1.00) NOTUMALDH1A1KDM4EKCNN4KCNA3
SCHEMBL29676976 0.73 KMT2A (0.50) NOTUMALDH1A1KDM4EMEN1CYP3A4
SCHEMBL8658474 0.73 KMT2A (0.50) NOTUMALDH1A1KDM4EMEN1CYP3A4
SCHEMBL28855145 0.69 NOTUM (0.58) NOTUMALDH1A1KDM4EMEN1CYP3A4
SCHEMBL6366299 0.69 NOTUM (0.58) NOTUMALDH1A1KDM4EMEN1CYP3A4
SCHEMBL30776885 0.69 NOTUM (0.58) NOTUMALDH1A1KDM4EMEN1CYP3A4
SCHEMBL7003872 0.68 NOTUM (0.73) NOTUMALDH1A1KDM4EMEN1CYP3A4
SCHEMBL27766277 0.68 HTT (0.45) NOTUMALDH1A1KDM4EMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1105393-B1 BICYCLIC PIPERIDINE AND PIPERAZINE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY NPS ALLELIX CORP (CA) 2003-10-01 EP disclosed
US-6562809-B1 Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor NPS ALLELIX CORP. (CA) 2003-05-13 US disclosed
EP-1114049-B1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS ALLELIX CORP (CA) 2003-03-19 EP disclosed
EP-1114049-A1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS Allelix Corp. (CA) 2001-07-11 EP disclosed
US-6251893-B1 TREATING CENTRAL NERVOUS SYSTEM DISORDERS NPS ALLELIX CORP. (CA) 2001-06-26 US disclosed
EP-1105393-A1 BICYCLIC PIPERIDINE AND PIPERAZINE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY NPS Allelix Corp. (CA) 2001-06-13 EP disclosed
WO-2000017198-A1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-03-30 WO disclosed
WO-1999065906-A1 BICYCLIC PIPERIDINE AND PIPERAZINE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1999-12-23 WO disclosed